Evidence map›Paper›PMID 24771909›Full record

ArticleGeburtshilfe und Frauenheilkunde2013

Epidemiology of Breast Cancer - Current Figures and Trends.

N Eisemann, A Waldmann, A Katalinic

Registry-linked trialAbstract read
In one paragraph

Article in Geburtshilfe und Frauenheilkunde, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04030728 (A Randomized, Controlled Study of Standardized Patient Coaching Versus Patient Management According to Local Practice for Patients With Hormone Receptor Positive HER2 Negative Metastatic Breast Cancer Treated With Abemaciclib), which is not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04030728 unknown statusnot on this mapstarted 2020, after this paper: background citation

A Randomized, Controlled Study of Standardized Patient Coaching Versus Patient Management According to Local Practice for Patients With Hormone Receptor Positive HER2 Negative Metastatic Breast Cancer Treated With Abemaciclib

TypeobservationalSponsorOnco Medical Consult GmbHRan2020 to 2021Enrolled212ConditionsMetastatic Breast Cancer, Advanced Breast Cancer
3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Intermammary breast cancer; the first reported case.International journal of surgery case reports · 2021
    Article
  6. Article
  7. Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer.Journal of enzyme inhibition and medicinal chemistry · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Cardiac Surgery is Safe in Female Patients with a History of Breast Cancer.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia · 2016
    Article
  15. Article
  16. After initial treatment for primary breast cancer: information needs, health literacy, and the role of health care workers.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
  17. The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian women.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

N EisemannInstitut für Krebsepidemiologie e. V., Lübeck.
A WaldmannInstitut für Klinische Epidemiologie, Lübeck.
A KatalinicInstitut für Krebsepidemiologie e. V., Lübeck ; Institut für Klinische Epidemiologie, Lübeck.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epidemiology of breast cancer has clearly changed in the past few years. On the basis of current data from population-based cancer registries characteristic numbers for incidence, prevalence, mortality and survival after breast cancer are presented. The number of incident cases has increased to around 72 000 in 2009 (+ 23 % since 2003). It is estimated that at present 250 000 women with a prevalent breast cancer (5-year prevalence) are living in Germany. The most frequent localisation is the outer upper quadrant of the breast. Poorly differentiated or undifferentiated tumour tissue is found in every third patient. Since 2003 the age-standardised mortality has declined slightly (- 9 %) whereas the relative survival has improved from 79 to 86 %. Changes in the epidemiology of breast cancer can most probably be attributed to the introduction of early detection programmes such as mammography screening as well as to improved treatment options. To what extent mammography screening will lead to a further reduction of mortality remains to be seen.

Indexed as

breast cancerepidemiologyincidencemortalityprevalenceprognosis

Identifiers

PMID24771909
PMCPMC3858992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.